Desensitization and test-dosing for the drug-allergic patient

Annals of Allergy, Asthma and Immunology

Volumn 85, Issue 4, 2000, Pages 250-251

  Greenberger, P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBENICILLIN; CD4 ANTIGEN; COTRIMOXAZOLE; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PREDNISONE; SULFONAMIDE; TICARCILLIN;

CLINICAL FEATURE; CLINICAL PROTOCOL; CYSTIC FIBROSIS; DESENSITIZATION; DOSE CALCULATION; DOSE RESPONSE; DRUG BINDING; DRUG SENSITIVITY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAST CELL; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PRURITUS; SKIN MANIFESTATION;

EID: 0033762075     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62526-4     Document Type: Editorial

References (27)

1. Drug allergy
2. Immunobiology. The immune system in health and disease, ed 2
3. Desensitization of anaphylactic hypersensitivity specific for the penicilloate minor determinant of penicillin and carbenicillin
4. Long-term ticarcillin desensitization by the continuous oral administration of penicillin
5. Adverse reactions to nonsteroidal anti-inflammatory drugs
6. Drug allergy and protocols for management of drug allergies
7. Desensitization to allopurinol in patients with gout and cutaneous reactions
8. Allopurinol sensitivity in a patient with chronic tophaceous gout: Success of intravenous desensitization after failure of oral desensitization
9. Management of drug allergy in patients with acquired immunodeficiency syndrome
10. The management of patients with sulfonamide allergy
11. Desensitization for sulfasalazine skin rash
12. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): Use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ
13. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients
14. Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome
15. Management of adverse reactions to prophylactic trimethoprim/sulfamethoxazole in patients with human immunodeficiency virus infection
16. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons
17. Current controversies in the management of allergic disease in HIV-positive patients
18. Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients
19. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients
20. Anaphylactic shock induced by oral desensitization to trimethoprim/sulfamethoxazole (TMP-SMZ)
21. Disease management of drug hypersensitivity: A practice parameter
22. The outcome of Stevens Johnson Syndrome treated with corticosteroids
23. Cutaneous disease and drug reactions in HIV infection
24. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection
25. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) is successful in patients with human immunodeficiency vires type-1 infection who were previously intolerant to T/S but had no sulfamethoxazole-specific IgE
26. Clinical and laboratory markers of hypersensitivity to trimethoprim/sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS
27. Corticosteroid therapy in an additional thirteen cases of Stevens Johnson Syndrome: A total series of sixty seven cases